The transcription factor NF-κB, a master regulator of innate and adaptive immune responses, inflammation, cell proliferation, and apoptosis, is implicated in the development and progression of various cardiometabolic disorders, including obesity, T2D, and CVD (54). This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.